Screening, diagnosis, and management of dyslipoproteinemia in children

Endocrinol Metab Clin North Am. 1990 Jun;19(2):399-449.

Abstract

The authors provide an extensive and comprehensive review of dyslipoproteinemia in children. An effective program for CVD reduction in this population will include an accessible screening program to identify high-risk children, high-quality measurements of TC and LP-C, careful follow-up of screening results with multiple measurement to classify risk status and diagnose primary dyslipidemia, a key role for family and education, and consistent and long-term follow-up for diet and drug adherence, efficacy, and safety.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Arteriosclerosis / etiology
  • Arteriosclerosis / prevention & control
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Child
  • Child, Preschool
  • Cholesterol / blood
  • Female
  • Humans
  • Hyperlipoproteinemias / complications
  • Hyperlipoproteinemias / diagnosis
  • Hyperlipoproteinemias / prevention & control*
  • Hyperlipoproteinemias / therapy
  • Hypolipoproteinemias / complications
  • Hypolipoproteinemias / diagnosis
  • Hypolipoproteinemias / prevention & control*
  • Hypolipoproteinemias / therapy
  • Infant
  • Lipoproteins / blood
  • Male
  • Mass Screening

Substances

  • Lipoproteins
  • Cholesterol